Keyphrases
Early Breast Cancer
70%
Postmenopausal Women
62%
Chemotherapy
57%
Breast Cancer Patients
45%
Women with Breast Cancer
39%
Adjuvant Chemotherapy
36%
Adjuvant Therapy
36%
Vibration Perception Threshold
33%
Thyroid Function
33%
Breast Cancer
31%
Chemotherapy-induced Peripheral Neuropathy
27%
Aromatase Inhibitors
24%
Postmenopausal Breast Cancer
24%
Chronic Nonbacterial Osteomyelitis
22%
Zoledronic Acid
22%
Chemotherapy-induced Neuropathy
22%
Prospective Observational Study
22%
Heart Rate Variability
22%
Mitochondrial Respiration
22%
Chemoradiotherapy
22%
Peripheral Blood Mononuclear Cells
20%
Breast Cancer Treatment
19%
Healthy Controls
17%
Weight Gain
17%
Threshold Frequency
17%
Weight Change
15%
Early Breast Cancer Patients
15%
Glucose Metabolism
14%
Adjuvant Radiotherapy
12%
Bone Mineral Density
12%
Antiestrogen
12%
Insulin Resistance
11%
Interim Analysis
11%
In Cancer
11%
Molecular Insight
11%
Treatment Effect
11%
Denosumab
11%
Acid Treatment
11%
Panacea
11%
Nutrition Metabolism
11%
Activity Metabolism
11%
Metabolic Dysregulation
11%
Bone Metabolism
11%
Osteomyelitis of the Jaw
11%
Chemotherapy-induced
11%
Letrozole
11%
Community-acquired
11%
Insulin Metabolism
11%
Encephalitis
11%
Advanced Breast Cancer
11%
Medicine and Dentistry
Breast Cancer
100%
Postmenopause
56%
Adjuvant Therapy
25%
Aromatase Inhibitor
24%
Glucose Metabolism
24%
Zoledronic Acid
22%
Systematic Review
22%
Perceptive Threshold
22%
Heart Rate Variability
22%
Vibration Sense
22%
Neuropathy
22%
Thyroid Function
22%
Adjuvant Chemotherapy
19%
Chemotherapy-Induced Peripheral Neuropathy
16%
Malignant Neoplasm
14%
Osteomyelitis
13%
Body Weight Change
12%
Bone Density
12%
Denosumab
11%
Insulin Metabolism
11%
Observational Study
11%
Bone Metabolism
11%
Treatment Effect
11%
Osteomyelitis of the Jaws
11%
Interim Analysis
11%
Lipid Metabolism
11%
Inflammatory Cytokine
11%
Analgesia
8%
Disease
8%
Radiation Therapy
7%
Insulin Resistance
7%
Patient-Reported Outcome
7%
Cancer Therapy
6%
Cytokine
6%
Triacylglycerol
5%
